Durability of the effects of testosterone and growth hormone supplementation in older community-dwelling men: The HORMA Trial

Clinical Endocrinology

Volumn 75, Issue 1, 2011, Pages 103-111

  Sattler, Fred R ^a,c   Bhasin, Shalender ^b   He, Jiaxiu ^c   Yarasheski, Kevin E ^d   Binder, Ellen F ^d   Schroeder, E Todd ^a   Castaneda Sceppa, Carmen ^e   Kawakubo, Miwa ^c   Roubenoff, Ronenn ^e   Dunn, Matthew ^c   Hahn, Chris ^c   Stewart, Yolanda ^a   Martinez, Carmen ^a   Azen, Stanley P ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HUMAN GROWTH HORMONE; LEUPRORELIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE; ANABOLIC AGENT;

AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY COMPOSITION; BODY MASS; CALORIC INTAKE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DAILY LIFE ACTIVITY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; EVENING DOSAGE; FOLLOW UP; GEL; HEMATOCRIT; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MUSCLE MASS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN INTAKE; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STRENGTH; SYSTOLIC BLOOD PRESSURE; UNSPECIFIED SIDE EFFECT; DIET SUPPLEMENTATION; TREATMENT OUTCOME;

AGED; ANABOLIC AGENTS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; HUMAN GROWTH HORMONE; HUMANS; MALE; TESTOSTERONE; TREATMENT OUTCOME;

EID: 79958856189     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04014.x     Document Type: Article

References (36)

1. Baumgartner, R.N., Koehler, K.M., Gallagher, D., et al. (1998) Epidemiology of sarcopenia among the elderly in New Mexico. American Journal of Epidemiology, 147, 755-763. (Pubitemid 28183275)
2. Larsson, L., Grimby, G., &, Karlsson, J., (1979) Muscle strength and speed of movement in relation to age and muscle morphology. Journal of Applied Physiology, 46, 451-456. (Pubitemid 9163080)
3. Dutta, C., Hadley, E., &, Lexell, J., (1997) Sarcopenia and physical performance in old age: overview. Muscle and Nerve. Supplement, 5, S5-S9. (Pubitemid 27418693)
4. Reaven, G.M., (1994) Syndrome X: 6 years later. Journal of Internal Medicine. Supplement, 736, 13-22.
5. Abbasi, A.A., Drinka, P.J., Mattson, D.E., et al. (1993) Low circulating levels of insulin-like growth factors and testosterone in chronically institutionalized elderly men. Journal of the American Geriatrics Society, 41, 975-982. (Pubitemid 23262325)
6. Harman, S.M., Metter, E.J., Tobin, J.D., et al. (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. Journal of Clinical Endocrinology and Metabolism, 86, 724-731. (Pubitemid 32207487)
7. Baumgartner, R.N., Waters, D.L., Gallagher, D., et al. (1999) Predictors of skeletal muscle mass in elderly men and women. Mechanisms of Ageing and Development, 107, 123-136. (Pubitemid 29138849)
8. Laughlin, G.A., Barrett-Connor, E., &, Bergstrom, J., (2008) Low serum testosterone and mortality in older men. Journal of Clinical Endocrinology and Metabolism, 93, 68-75.
9. Kupelian, V., Page, S.T., Araujo, A.B., et al. (2006) Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. Journal of Clinical Endocrinology and Metabolism, 91, 843-850. (Pubitemid 43357748)
10. Rudman, D., Feller, A.G., Nagraj, H.S., et al. (1990) Effects of human growth hormone in men over 60 years old [see comments]. New England Journal of Medicine, 323, 1-6. (Pubitemid 20209464)
11. Marin, P., Kvist, H., Lindstedt, G., et al. (1993) Low concentrations of insulin-like growth factor-I in abdominal obesity. International Journal of Obesity and Related Metabolic Disorders, 17, 83-89. (Pubitemid 23088119)
12. Snel, Y.E., Doerga, M.E., Brummer, R.M., et al. (1995) Magnetic resonance imaging-assessed adipose tissue and serum lipid and insulin concentrations in growth hormone-deficient adults. Effect of growth hormone replacement. Arteriosclerosis, Thrombosis, and Vascular Biology, 15, 1543-1548.
13. Sattler, F.R., Castaneda-Sceppa, C., Binder, E.F., et al. (2009) Testosterone and growth hormone improve body composition and muscle performance in older men. Journal of Clinical Endocrinology and Metabolism, 94, 1991-2001.
14. Blackman, M.R., Sorkin, J.D., Munzer, T., et al. (2002) Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA, 288, 2282-2292. (Pubitemid 35291758)
15. Brill, K.T., Weltman, A.L., Gentili, A., et al. (2002) Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men. Journal of Clinical Endocrinology and Metabolism, 87, 5649-5657. (Pubitemid 36034373)
16. Nair, K.S., Rizza, R.A., O'Brien, P., et al. (2006) DHEA in elderly women and DHEA or testosterone in elderly men. New England Journal of Medicine, 355, 1647-1659. (Pubitemid 44583955)
17. Papadakis, M.A., Grady, D., Black, D., et al. (1996) Growth hormone replacement in healthy older men improves body composition but not functional ability [see comments]. Annals of Internal Medicine, 124, 708-716. (Pubitemid 26117919)
18. Emmelot-Vonk, M.H., Verhaar, H.J., Nakhai Pour, H.R., et al. (2008) Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. JAMA, 299, 39-52.
19. Giannoulis, M.G., Sonksen, P.H., Umpleby, M., et al. (2006) The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial. Journal of Clinical Endocrinology and Metabolism, 91, 477-484. (Pubitemid 43236912)
20. Basaria, S., Coviello, A.D., Travison, T.G., et al. (2010) Adverse events associated with testosterone administration. New England Journal of Medicine, 363, 109-122.
21. Lucidi, P., Lauteri, M., Laureti, S., et al. (1998) A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism, 83, 353-357. (Pubitemid 28496505)
22. Toogood, A.A., &, Shalet, S.M., (1999) Growth hormone replacement therapy in the elderly with hypothalamic-pituitary disease: a dose-finding study. Journal of Clinical Endocrinology and Metabolism, 84, 131-136. (Pubitemid 29036691)
23. Frontera, W.R., Hughes, V.A., Dallal, G.E., et al. (1993) Reliability of isokinetic muscle strength testing in 45- to 78-year-old men and women. Archives of Physical Medicine and Rehabilitation, 74, 1181-1185. (Pubitemid 23315104)
24. Gray, P.B., Singh, A.B., Woodhouse, L.J., et al. (2005) Dose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older men. Journal of Clinical Endocrinology and Metabolism, 90, 3838-3846. (Pubitemid 41058141)
25. Wang, C., Alexander, G., Berman, N., et al. (1996) Testosterone replacement therapy improves mood in hypogonadal men-a clinical research center study. Journal of Clinical Endocrinology and Metabolism, 81, 3578-3583. (Pubitemid 26339918)
26. Sathiavageeswaran, M., Burman, P., Lawrence, D., et al. (2007) Effects of GH on cognitive function in elderly patients with adult-onset GH deficiency: a placebo-controlled 12-month study. European Journal of Endocrinology, 156, 439-447. (Pubitemid 46672644)
27. Arwert, L.I., Deijen, J.B., Muller, M., et al. (2005) Long-term growth hormone treatment preserves GH-induced memory and mood improvements: a 10-year follow-up study in GH-deficient adult men. Hormones and Behavior, 47, 343-349. (Pubitemid 40222742)
28. Azad, N., Pitale, S., Barnes, W.E., et al. (2003) Testosterone treatment enhances regional brain perfusion in hypogonadal men. Journal of Clinical Endocrinology and Metabolism, 88, 3064-3068. (Pubitemid 36877473)
29. Arwert, L.I., Veltman, D.J., Deijen, J.B., et al. (2005) Memory performance and the growth hormone/insulin-like growth factor axis in elderly: a positron emission tomography study. Neuroendocrinology, 81, 31-40. (Pubitemid 40868725)
30. Marin, P., (1995) Testosterone and regional fat distribution. Obesity Research, 3 (Suppl 4), 609S-612S.
31. Johannsson, G., Marin, P., Lonn, L., et al. (1997) Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure [see comments]. Journal of Clinical Endocrinology and Metabolism, 82, 727-734. (Pubitemid 27106578)
32. Marin, P., Krotkiewski, M., &, Bjorntorp, P., (1992) Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues. European Journal of Medicine, 1, 329-336.
33. Singh, A.B., Hsia, S., Alaupovic, P., et al. (2002) The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men. Journal of Clinical Endocrinology and Metabolism, 87, 136-143. (Pubitemid 34084682)
34. Rosenfalck, A.M., Fisker, S., Hilsted, J., et al. (1999) The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy. Growth Hormone IGF Research Society, 9, 96-105. (Pubitemid 29320366)
35. White, H.K., Petrie, C.D., Landschulz, W., et al. (2009) Effects of an oral growth hormone secretagogue in older adults. Journal of Clinical Endocrinology and Metabolism, 94, 1198-1206.
36. Nass, R., Pezzoli, S.S., Oliveri, M.C., et al. (2008) Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Annals of Internal Medicine, 149, 601-611.